A study reported that BMMSCs can decrease levels of tubular CCL-2, CCL-5, TNF-α, α-SMA, fibronectin (FN), and collagen IV and finally reduce tubular EMT and renal fibrosis in albumin-overloaded mice. The gene discussed is CCL5; the disease is renal fibrosis.